The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Gastroenteritis Testing Market Change Between 2026 And 2030?
The gastroenteritis testing market size has experienced significant expansion in recent years. This market is projected to grow from $4.18 billion in 2025 to $4.44 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be attributed to several factors including reliance on conventional immunoassay and culture-based methods, limited availability of advanced molecular diagnostics, an increasing prevalence of gastrointestinal infections, rising hospital and clinic diagnostic capabilities, and the expansion of research institutes engaged in infectious disease studies.
The market size for gastroenteritis testing is expected to experience substantial growth in the upcoming years. It is projected to grow to $5.55 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.8%. The expansion during the forecast period can be attributed to advancements in molecular diagnostic technologies, a growing demand for rapid point-of-care testing, increased funding for infectious disease research, the rising adoption of integrated laboratory information systems, and the spread of gastroenteritis testing into emerging markets. Key trends anticipated in the forecast period include a heightened demand for rapid and accurate gastroenteritis diagnostics, an increase in the adoption of molecular diagnostic testing methods, the expansion of viral, bacterial, and parasitic testing panels, growth in both point-of-care testing and hospital-based diagnostics, and an enhanced focus on epidemiological surveillance and outbreak management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp
Which Strategic Drivers Are Supporting The Gastroenteritis Testing Market Development?
The escalating incidence of bacterial infections is projected to drive the expansion of the gastroenteritis testing market. Bacterial infections are on the rise due to increased antibiotic resistance, higher population densities, and more extensive global travel, which together facilitate the spread of resistant bacteria. Gastroenteritis testing becomes essential for bacterial infections to accurately identify the specific pathogen causing symptoms such as diarrhea and vomiting, which in turn informs appropriate treatment strategies and prevents further spread of the infection. For example, in 2024, data from the GOV.UK, a UK-based organization, revealed that serious cases of bacteraemia caused by antibiotic-resistant bacteria had increased by 9.3% since 2023, growing from 18,740 cases in 2023 to 20,484 cases in 2024. Therefore, the growing occurrence of bacterial infections is propelling the growth of the gastroenteritis testing market.
What Segment Types Are Included In The Gastroenteritis Testing Market Analysis?
The gastroenteritis testing market covered in this report is segmented –
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis
Which Trends Are Influencing The Expansion Of The Gastroenteritis Testing Market?
Leading companies in the gastroenteritis testing market are developing advanced products, such as molecular gastrointestinal tests, to deliver high sensitivity and specificity. A molecular gastrointestinal test serves as a diagnostic approach utilizing molecular techniques, like polymerase chain reaction (PCR), to identify and detect specific genetic material from pathogens or organisms within gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a Germany-based supplier of sample and assay technologies, introduced its QIAstat-Dx Gastrointestinal Panel 2. This panel stands out for its capability to quickly and extensively detect up to 16 clinically important bacterial, viral, and parasitic pathogens responsible for most gastrointestinal infections. It incorporates real-time polymerase chain reaction (PCR) technology to amplify multiple genetic targets in a single reaction, representing a considerable enhancement over traditional microbiological procedures that typically require 24 hours to 10 days for sample incubation.
Which Companies Are Engaged In The Gastroenteritis Testing Market Environment?
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation
Access The Complete Gastroenteritis Testing Market Report:
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report
Which Region Holds The Largest Share In The Gastroenteritis Testing Market?
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Gastroenteritis Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report
Browse Through More Reports Similar to the Global Gastroenteritis Testing Market 2026, By The Business Research Company
Gastroesophageal Reflux Disease Gerd Market Report 2026
Immunochemistry Diagnostic Devices And Equipment Market Report 2026
Cardiac Rhythm Management Crm Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model